H.Res. 1437

H.Res. 1437: Recognizing that equity, diversity, and inclusion in federally funded health research is necessary to enhance scientific excellence, and ensure equitable outcomes for patients in the United States.

Introduced Debbie Dingell (D) HOUSE_RESOLUTION — 119th Congress
Plain English Summary

H.Res. 1437 is a resolution that acknowledges the importance of equity, diversity, and inclusion in health research that receives federal funding. The bill emphasizes that these principles are essential for improving scientific quality and achieving fair healthcare outcomes for all patients in the U.S.

Positive Media Summary

Many media outlets have praised H.Res. 1437 for its commitment to promoting diversity and inclusion in health research. Supporters argue that diverse research teams are more likely to address the needs of a varied patient population, leading to better health outcomes and advancements in medical science.

Negative Media Summary

Critics of H.Res. 1437 have raised concerns about the potential for political motivations behind the push for equity and diversity in health research. Some argue that focusing on these factors could detract from the merit-based selection of research projects, potentially compromising scientific integrity and excellence.

Conflict of Interest Analysis Deep Analysis
3/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

While there are no direct industry overlaps between the bill's subject matter and the sponsor's top donor industries, there is significant lobbying activity in the health research policy area. Notably, Henkel of America Inc. has contributed $105,000, which could indicate a vested interest in health-related outcomes. Additionally, the National Federation of State High School Associations has made contributions totaling $15,000, which may suggest an interest in health equity related to youth sports. Although the direct connections are not evident, the presence of substantial lobbying funds indicates potential influences that could affect the bill's outcomes. Voters should be aware that while the bill aims to promote equity in health research, the financial interests of lobbyists could shape its implementation.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
HENKEL OF AMERICA INC. HENKEL OF AMERICA INC. $105,000
CONSTELLIUM ROLLED PRODUCTS RAVENSWOOD, LLC EDWARD C. OLIVARES, LLC $50,000
LA ROCHE UNIVERSITY MCALLISTER & QUINN, LLC $30,000
L3HARRIS TECHNOLOGIES MCALLISTER & QUINN, LLC $30,000
METROPOLITAN ST LOUIS SEWER DISTRICT CARDINAL POINT PARTNERS $20,000
NATIONAL FEDERATION OF STATE HIGH SCHOOL ASSOCIATIONS REPUBLIC CONSULTING, LLC $10,000
NATIONAL FEDERATION OF STATE HIGH SCHOOL ASSOCIATIONS REPUBLIC CONSULTING, LLC $5,000
KERING AMERICAS, INC. CAPITOL KNOWLEDGE, LLC undisclosed
STUEVE SIEGEL HANSON LLP CENTER MARKET STRATEGIES, LLC undisclosed
WILKES COUNTY, NC THE FERGUSON GROUP undisclosed
DAVIS GEORGE CENTER MARKET STRATEGIES, LLC undisclosed
MASSIF MCALLISTER & QUINN, LLC undisclosed
HEALTHY MARKETS ASSOCIATION CENTER MARKET STRATEGIES, LLC undisclosed
LEWIS UNIVERSITY MCALLISTER & QUINN, LLC undisclosed
RF CHECK, INC CARDINAL POINT PARTNERS undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Debbie Dingell, ranked by total contributions.

Health Professionals $240,000,000
Individuals: $240,000,000 PACs: $0
Retired $75,000,000
Individuals: $75,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us